Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
Propanc Biopharma, Inc. (PPCB)
Activity window: Sep. 25, 2025 to Sep. 24, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 16, 2026 | CORRESP | Neutral/Informational | Moderate | Propanc Biopharma, Inc. has submitted a request to the SEC to expedite the effectiveness of their Registration Statement on Form S-1, originally filed on April 10, 2026. They are … | Read Filing EDGAR |
| Apr. 15, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Propanc Biopharma, Inc. that it will not review the company's registration statement filed on April 10, 2026. This indicates that the SEC is not moving… | Read Filing EDGAR |
| Feb. 20, 2026 | CORRESP | Neutral/Informational | Moderate | Propanc Biopharma, Inc. has submitted a request to the SEC for the effectiveness of their Registration Statement on Form S-1, filed on February 19, 2026. They are seeking to have … | Read Filing EDGAR |
| Feb. 12, 2026 | CORRESP | Neutral/Informational | Low | Propanc Biopharma, Inc. has formally requested the withdrawal of its previous request for the acceleration of the effective date of its Registration Statement on Form S-1. Initial… | Read Filing EDGAR |
| Feb. 10, 2026 | UPLOAD | Concern from SEC | Moderate | The SEC has communicated to Propanc Biopharma, Inc. that they will not review the company's registration statement filed on February 2, 2026. The SEC reminds the company that it i… | Read Filing EDGAR |
| Feb. 10, 2026 | CORRESP | Neutral/Informational | Moderate | Propanc Biopharma, Inc. has submitted a request to the SEC for the effectiveness of their Registration Statement on Form S-1, which was filed on February 2, 2026. They are seeking… | Read Filing EDGAR |
| Jan. 6, 2026 | CORRESP | Neutral/Informational | Moderate | Propanc Biopharma, Inc. has submitted a request to the SEC for the effectiveness of their Registration Statement on Form S-1, which was filed on December 30, 2025. They are seekin… | Read Filing EDGAR |
| Jan. 5, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Propanc Biopharma, Inc. that it will not review their registration statement filed on December 30, 2025. The letter emphasizes that the responsibility … | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.